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Purpose: Transforming growth factor beta-induced protein (TGFBIp) aggregates into the phenotypic amyloid fibrils and/
or non-amyloid deposits in corneal dystrophies and other disorders. While significant progress has been made in molecular
genetics to successfully establish the link between the missense mutations of TGFBI and TGFBIp-related corneal
dystrophies, the underlying mechanism for the abnormal aggregation remains elusive due to the lack of insights into the
conformational perturbations induced by mutations. In the present study, we examined the effects of denaturants and a
co-solvent on recombinant TGFBIp, with a focus on protein conformational changes and amyloid fibril formation.
Methods: Recombinant TGFBIp was subjected to various spectroscopic studies, such as far-ultraviolet circular dichroism
(far-UV  CD),  intrinsic  tryptophan  fluorescence  and  quenching,  and  1-anilinonaphthalene-8-sulfonic  acid  (ANS)
fluorescence,  under  various  denaturing  conditions  (urea  and  guanidine  hydrochloride  [GndHCl],  acidic  pH,  and
trifluoroethanol [TFE, co-solvent]). A thioflavin T (ThT) fluorescence assay was used to determine the fibril formation
of TGFBIp. In addition, a rabbit polyclonal antibody against the oligomer precursors that initiate the formation of amyloid
fibrils was also used in dot blot experiments to detect the formation of prefibrillar precursors.
Results: The purified recombinant TGFBIp is in the folded state according to its intrinsic tryptophan fluorescence analyses.
A single-step unfolding process was observed in the GndHCl denaturation experiment. Results from far-UV CD, intrinsic
tryptophan fluorescence, and ANS fluorescence experiments showed that TFE exerted its solvent effects by initially
unfolding and transforming TGFBIp to a β-sheet-enriched conformer at 20%. When increased to 40%, TFE changed
TGFBIp into a non-native α-helix conformer. Although GndHCl and TFE led to protein unfolding, enhanced fibril
formation could only be observed in the presence of TFE and at acidic pH, according to the ThT fluorescence assays. The
paradigmatic protofibrillar TGFBIp oligomers were also detected during the fibril formation by the dot blot experiment.
Conclusions: Our results suggest that protein unfolding may serve as the prerequisite but is not sufficient for the
fibrillogenesis. Other factors, such as the solvent used, fragmentation, or pH, may also be crucial for the formation of
TGFBIp fibrils.
Pathological  protein  aggregations,  particularly
amyloidosis, affect almost all tissues and organs and have
been  implicated  in  various  human  diseases,  such  as
Alzheimer’s  disease,  Creutzfeldt-Jakob  disease,  familial
amyloidotic polyneuropathy, Parkinson’s disease, and others
[1-3].  Corneal  amyloidosis  disorders,  including  gelsolin-
related lattice corneal dystrophy type II (Finnish-type familial
amyloid polyneuropathy type IV), lactoferrin-related familial
subepithelial amyloidosis, transforming growth factor beta-
induced  gene  (TGFBI)-related  corneal  dystrophies,  and
polymorphic  amyloid  degeneration,  are  characterized  by
phenotypic  abnormal  deposits  accompanied  by  corneal
opacities, epithelial abnormalities, pain, and potential loss of
vision [4]. In addition to those pathogenic gene mutations that
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either have systemic effects or specifically affect only corneal
tissues, secondary amyloidosis has been reported in various
ocular  disorders,  such  as  keratitis,  chronic  post-traumatic
inflammation,  glaucoma,  keratoconus,  trichiasis,  and  even
Fuch’s endothelial dystrophies [5-7]. Among these various
types  of  corneal  amyloidosis  disorders,  TGFBIp-related
corneal dystrophies are perhaps the most well studied.
TGFBIp (the protein product of the TGFBI gene, also
referred to as keratoepithelin, BIGH3, beta-igh3, βigh3, or
RGD-CAP)  is  a  683-amino  acid  secretory  matrix  protein
induced by transforming growth factor β-1. It plays essential
roles  in  cell  adhesion,  differentiation,  and  tumorigenesis
[8-13].  The  temporal  expression  of  TGFBI  during
embryogenesis  and  wound  healing  suggests  its  important
roles in the development and maintenance of ocular surface
integrity [14-16]. Primary sequence analysis reveals that the
encoded TGFBIp contains a secretory signal peptide sequence
in  the  NH2-terminus,  and  an  arginine-glycine-aspartate
(RGD) motif located at the COOH-terminal end, which can
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2617mediate cell adhesion and other functions via integrins [17].
In addition, there are four homologous repeats designated as
“Fas-like”  domains  in  TGFBIp  [18].  The  RGD  motif  in
TGFBIp  may  not  be  involved  in  integrin-mediated  cell
adhesion, but rather in other events, such as apoptosis [19,
20]. Mass spectroscopy has indicated that mature TGFBIp
from CHO cells does not contain the RGD motif, likely as a
consequence of post-translational degradation [21]. Instead,
novel motifs (NKDIL and EPDIM) located in the second and
fourth  Fas-like  domains  were  identified  as  exerting  an
integrin-binding capability [10].
The pathogenic roles of mutant TGFBIp in certain types
of stromal corneal dystrophies have drawn great attention
since TGFBIp’s discovery in 1992 [8]. Genetic analyses [22]
have linked several mutations of the TGFBI gene to various
corneal dystrophies, including Avellino, lattice dystrophies,
Reis-Bucklers  dystrophies,  and  granular  dystrophies.
Currently, more than 30 missense mutations of TGFBI have
been identified and linked to at least 13 different phenotypes
of  corneal  dystrophies,  characterized  by  the  presence  of
abnormal amyloid fibril and/or non-amyloid deposits in sub-
epithelial and stromal layers in the cornea [4,23,24]. Painful
corneal  erosions  often  recur,  likely  due  to  poor  epithelial
adhesions.  Interestingly,  almost  all  the  dystrophy-related
mutations are clustered in the first and fourth Fas-like domains
(Fas-1 and Fas-4). While the role of genetic predisposition has
been well established, it is likely that the genetic mutation is
not the only determinant contributing to the amyloid fibril and
non-amyloid  aggregations  in  TGFBIp-related  corneal
dystrophies.  The  fact  that  both  wild-type  and  mutant
recombinant  TGFBIp  readily  form  amyloid  fibrils  [10]
strongly suggests an intrinsic propensity of TGFBIp toward
aggregations  and  a  potential  pathogenesis  mechanism.
Previous  studies  also  indicate  that  TGFBIp  contains
amyloidogenic  motifs  that  play  essential  roles  in  the
aggregation  mechanism,  similar  to  other  disease-related
amyloidogenic  proteins  such  as  amyloid  beta  precursor
protein or lysozymes. Using synthetic peptide approaches, at
least  two  endogenous  amyloidogenic  motifs  on  TGFBIp,
spanning from residues 110 to 131 and from 515 to 532,
respectively, have been identified [25-27]. However, the role
of these amyloidogenic motifs for amyloid fibril formation
within  the  full-length  protein  context  awaits  further
investigation. In addition, tissue-specific protein or matrix
degradation may also play roles in the pathogenesis of the
abnormal aggregations of TGFBIp [28].
Protein  conformational  change  and  unfolding  are
proposed to be the prevailing mechanisms for amyloid fibril
formation [29]. Studying the molecular properties of disease-
related proteins under amyloid-conducive conditions should
shed light on the protein aggregation behavior and related
pathogenic pathways. Furthermore, studies with recombinant
proteins are currently the only avenue for understanding the
mechanism  of  amyloid  fibril  formation  of  TGFBIp,  since
transgenic  animal  models  have  failed  to  manifest  corneal
dystrophic phenotypes [30]. In this study, we set forth to
characterize the conformational properties of TGFBIp with
spectroscopic tools, and have investigated the denaturation
profile and the effects of pH and solvent on its conformations
and fibril formation.
METHODS
Materials: All chemical reagents were purchased from Sigma
Chemical Co. (St. Louis, MO), if not otherwise specified.
Puromycin was purchased from Clontech (Mountain View,
CA).  Rabbit  anti-oligomer  polyclonal  antibody  that
recognizes the amino acid sequence-independent oligomeric
conformers of various amyloidogenic proteins was purchased
from BioSource International (Camarillo, CA). Rabbit anti-
TGFBIp polyclonal antibody was custom-made by Bethyl
Laboratory (Montgomery, TX). E. coli-expressed full-length
recombinant  TGFBIp  was  used  as  the  antigen  for
immunization [31].
Production of recombinant proteins: The TGFBIp coding
sequence from 1 to 641 residues with the RGD motif removed
(resembling the matured form of the secreted protein) was
PCR-amplified  from  an  I.M.A.G.E.  clone  (Clone  I.D.
2957915;  Genbank  BE206112),  and  inserted  into
pIRES.puro3  for  stable  expression  in  mammalian  cells
(293FT; Invitrogen, Carlsbad, CA). (His)6 and Strep II tags
were engineered to be expressed right after the encoded signal
peptide  and  in  the  COOH-terminal  end,  respectively,  to
facilitate the subsequent purification. After transfection, cells
were maintained in Dulbecco's Modified Eagle Medium plus
10% fetal bovine serum under puromycin selection (3 μg/ml)
for two weeks. Individual clones were selected according to
their  growth  rates  and  TGFBIp  expression  level  (as
determined by dot blot experiments). The TGFBIp-expressing
clones were further expanded in a serum-free medium system
(FreeStyleTM 293, Invitrogen) with reduced puromycin (1 μg/
ml). Secreted TGFBIp in the conditioned medium was loaded
onto  a  Ni+-NTA  column  for  single-step  purification.  The
purities of recombinant WT TGFBIp were confirmed by SDS-
PAGE gels and were routinely higher than 95%. Purified
TGFBIp were further concentrated using Centriprep YM-30
(Amicon,  Bedford,  MA)  to  the  intended  concentrations
determined by the BCA assay (Pierce, Rockford, IL).
Fluorescence quenching experiments: Fluorescence studies
were  performed  using  a  FluoroMax-II  spectrofluorometer
(Jobin  Yvon-SPEX,  Edison,  NJ).  Intrinsic  tryptophan
fluorescence spectra of recombinant TGFBIp (approximately
0.1 mg/ml in 50 mM Tris-HCl, 150 mM NaCl, pH 7.4) were
taken  in  a  1  cm  quartz  cuvette  at  25  oC.  Quenching
experiments were carried out by adding aliquots of acrylamide
or potassium iodide (KI) stock solutions (5 M) sequentially
into  recombinant  TGFBIp  samples.  The  excitation
wavelength was 295 nm (tryptophan) and the emission spectra
were scanned from 300 to 500 nm. Sodium thiosulfate (0.1
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2618mM)  was  added  to  the  KI  stock  solution  to  prevent  the
formation of I3
-, which has a yellowish color that interferes
with the spectroscopic measurement. The emission intensities
at 330 nm in the absence and in the presence of a quencher
(Fo and FOBS) were used for the Stern-Volmer analyses [32,
33]. The data were further corrected for the dilution and the
inner filtering effect accordingly [34,35]:
FCORR = FOBS*D*10exp (Aex + Aem)/2
where  FCORR  and  FOBS  are  the  corrected  and  observed
fluorescence, respectively, and D is the dilution factor due to
the volume increase from the added quencher; Aex and Aem are
the absorption of the quencher at the excitation and emission
wavelengths,  respectively.  As  the  plot  of  F0/F  versus
acrylamide  appeared  to  be  linear  (see  Results),  the  two
tryptophan  residues  (TGFBIp  contains  two  tryptophan
residues,  W68  and  W148)  likely  have  heterogeneous
fluorescence behaviors, but only differ by a factor of less than
2 within the experimental error [32]. Therefore, the effective
quenching  constant,  KSV(eff),  was  determined  by  plotting
(Fo/F-1)/[Q] versus [Q] ([Q], concentration of the quencher)
and extrapolating to [Q]=0, where the initial slope can be
obtained for the value of KSV(eff).
Fluorescence  spectroscopy:  For  the  denaturation
experiments, the emission maximum (“Emax”) and intensity-
averaged emission maximum (“IAEM,” [λ]=Σ (λi*Ii) / Σ λi,
where  Ii  is  the  fluorescence  intensity  at  the  individual
wavelength λI) of tryptophan residues were used as indicators
for the unfolding/denaturation of TGFBIp in the presence of
guanidine  hydrochloride  (GndHCl)  or  urea  [36].  For
Thioflavin T (ThT) assays, 100 μl samples were mixed with
700 μl of 25 μM ThT in 50 mM glycine-NaOH, pH 8.5, and
then immediately measured for their ThT fluorescence spectra
(excited at 450 nm and scanned from 460 nm to 600 nm). For
the  pH-dependent  amyloid  fibril  formation,  recombinant
TGFBIp were mixed with the buffering solution containing
150 mM NaCl and 50 mM of sodium citrate, MES, MOPS,
Tris, CHES, and CAPS [27], with pH ranging from 2 to 13.
The  formed  fibrils  were  further  spun  down  by  a  TL-100
ultracentrifuge (Beckman Coulter, Fullerton, CA) at 38,500×
g (25,000 rpm), washed once in 50 mM Tris-HCl, 150 mM
NaCl, pH 7.4 solution and then resuspended in ThT solution
for the ThT fluorescence assays to reduce the interference by
pH.  The  fluorescence  of  1  anilino-naphthalene-8-sulfonic
acid (ANS) was used as a spectroscopic tool to investigate the
hydrophobicity  of  recombinant  TGFBIp  in  various
conditions. Samples in 50 μM ANS, 50 mM Tris-HCl, pH 7.4
were measured using an excitation wavelength of 350 nm and
scanned from 400 to 600 nm.
Circular  dichroism  spectroscopy:  The  far-UV  circular
dichroism  (CD)  spectra  were  measured  by  a  Jasco  J-710
spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan).
Each spectrum was obtained from the average of ten scans
with blank-subtraction, smoothed by a binomial smoothing
routine, and plotted using Kaleidagraph software (Synergy
Software, Reading, PA).
Electron microscopy: Samples of TGFBIp were incubated at
37 oC in 50 mM Tris-HCl, 150 mM NaCl, pH 7.4 for up to
one week. Five microliters of sample were applied onto a
carbon-coated  formvar  copper  grid  and  stained  with  2%
phosphotungstic acid at pH 7.4 at room temperature for 2 min.
The fibrils were examined with a JEOL 1200 transmission
electron  microscope  at  the  University  of  Minnesota
Characterization facility.
RESULTS
Production of recombinant TGFBIp: In order to obtain highly
pure, homogeneous TGFBIp for biochemical and biophysical
studies, we have constructed and evaluated various expression
vectors (Figure 1A) for recombinant protein production. In
contrast to the extensive degradation patterns of recombinant
TGFBIp (lane 1, Figure 1B) produced by the single-tagged
construct (“[His]6-TGFBIp”, Figure 1A), the double-tagged
construct with the RGD motif removed (“[His]6-TGFBIp-
[Strep  II]”,  Figure  1A)  generates  a  single  major  protein
product (lane 2, Figure 1B). On average, 6–8 mg of purified
recombinant TGFBIp was obtained from 1 liter of conditioned
medium  using  a  single-step  Ni+-NTA  affinity
chromatography,  with  purities  greater  than  95%,  as
demonstrated by SDS-PAGE gel electrophoresis. Previously,
WT TGFBIp and peptides have been shown to form fibrils in
vitro  by  various  researchers  [25-27,37].  Recombinant
TGFBIp  produced  in  this  study  formed  fibrils,  as
demonstrated by the ThT fluorescence assay (Figure 1C) and
electron microscopy (Figure 1D) when incubated in the Tris-
buffered saline (1× TBS) at 37 oC for one week. Fibrils of 5–
10 nm in width and up to several hundred nm in length were
observed after extensive incubation at 37 oC (Figure 1D).
Denaturation  profile  by  urea  and  GndHCl:  The  intrinsic
tryptophan fluorescence of recombinant WT TGFBIp was
studied for the denaturation profile using urea and GndHCl.
The tryptophan residues display a fluorescence emission peak
at 330 nm (Ex=295 nm) in the native state (Figure 2A, 0.0 M
GndHCl), indicating that they are in a relative hydrophobic
environment. Results from quenching experiments revealed
that acrylamide, a non-ionic polar quencher, is able to quench
the intrinsic tryptophan fluorescence effectively (Figure 2A,
inset).  I-,  on  the  other  hand,  failed  to  produce  evident
quenching below the concentration of 1 M. Stern-Volmer
analyses  of  the  quenching  experiments  by  acrylamide
revealed a linear plot, suggesting that the collisional constants
of the two tryptophans differ by less than two-fold [32]. The
effective  collisional  quenching  constant  KSV(eff)  was
determined to be 4.63 M-1.
Exposure of tryptophan to the hydrophilic environment
during protein unfolding results in a redshift of the emission
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2619maximum and a change in the quantum yield. The addition of
1.0 to 6.0 M GndHCl produced a significant redshift of the
emission  maximum  from  330  to  355  nm,  along  with  a
significant reduction of fluorescence intensity, as shown in
Figure  2A.  The  concentration  of  the  half-transition  by
GndHCl denaturation was determined to be approximately 3.5
M (Figure 2B), by both Emax and IAEM. The latter index was
calculated from the entire spectrum and reflects both the shape
and position changes, and is therefore less susceptible to error
[36]. The curve-fittings with either indexe also suggested a
simple two-state denaturation profile (native and denatured
states)  by  GndHCl.  Reduction  of  the  total  fluorescence
intensity  was  also  observed  with  increasing  GndHCl
concentration that approximates a two-state transition (data
not shown). Urea at concentrations of up to 8 M, on the other
hand, failed to denature recombinant TGFBIp (Figure 2B,
inset)  and  merely  produced  a  4  nm  shift  of  the  emission
maximum (from 330 to 334 nm), in contrast to the 25 nm
redshift caused by 6 M GndHCl. When WT TGFBIp was
incubated with GndHCl at various concentrations that either
partially (1 or 2 M) or fully (4 or 6 M) denatured the protein,
no  fibril  formation  was  observed  according  to  the  ThT
fluorescence assays (Figure 2C).
pH effect on fibril formation: The pH effects on the fibril
formation  of  TGFBIps  were  investigated  by  incubating
recombinant  proteins  at  various  pHs  for  24  h  at  37  oC.
TGFBIps were instantly denatured in alkaline pH (pH 13), as
demonstrated  by  the  prominent  redshift  of  the  emission
maxima of the tryptophan residues (“pH 13”, Figure 3A inset),
while aggregations of TGFBIp were promoted in acidic pHs
conditions, judging from the elevated light scattering from the
baseline  (“pH  3”  versus  “pH  7”  in  Figure  3A,  inset).
Significant increases of fibril formations measured by ThT
fluorescence  assay  were  noted  at  conditions  below  pH  6
(Figure 3A) and reached a plateau at pH 3. On the other hand,
the ThT fluorescence intensities remained minimal above pH
6. SDS-PAGE analyses showed that increased fragmentation
of TGFBIp occurred at pH 3 after 24 h incubation (37  oC,
Figure  3B).  Such  a  degradation  in  acidic  pH  was  further
enhanced by elevating the incubation temperature to 60 oC
(Figure 3B).
Figure 1. The recombinant transforming
growth  factor  beta-induced  protein
(TGFBIp)  was  successfully  expressed
using mammalian cells. A: The TGFBI
cDNA with various motifs were used for
the  expression  in  mammalian  cells.
"(His)6": polyhistidine tag; "Strep II":
strep  II  tag;  "Fas":  Fasciclin-like
domain;  "RGD":  arginine-glycine-
aspartate motif. B: Purified recombinant
TGFBIp were analyzed on a 12% SDS-
PAGE gel. “St’d”: molecular markers;
lane  1:  single-tagged  (His)6-TGFBIp;
lane 2: double-tagged (His)6-TGFBIp-
(Strep  II)  protein.  The  amyloid  fibril
formation of recombinant TGFBIp was
obtained  after  incubation  in  1×  Tris-
buffered saline at 37 °C for one week, as
demonstrated  by  C:  thioflavin  (ThT)
fluorescence  spectroscopy  and  by  D:
electron  microscopy  (75,000×
magnification).
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2620Trifluoroethanol promotes the unfolding and fibril formation
of recombinant TGFBIp: As solvation plays essential roles in
amyloid fibril formation, we further investigated the solvent
effects of trifluoroethanol (TFE) on the conformation and
fibril  formation  of  recombinant  TGFBIp.  The  emission
maxima of the intrinsic tryptophan fluorescence of TGFBIp
were approximately 330 nm in 0–10% TFE (Figure 4A), with
the slight reduction of the intensities likely due to the reduced
quantum  yield  in  the  presence  of  TFE.  At  20%  TFE,
significant  conformational  changes  of  TGFBIp  occurred,
which is indicated by the shift of the emission maximum
toward the red (approximately 348 nm), along with some
degree of aggregations reflected by the uprising of the baseline
toward the blue (light scattering). At 40% TFE, the tryptophan
residues further redshift to approximately 351 nm.
ANS fluoresces to a much higher degree when it binds to
exposed hydrophobic patches, and therefore has been used as
an indicator for protein unfolding. When ANS was used to
probe  the  unfolding  of  TGFBIp  at  various  TFE
concentrations,  minor  changes  of  ANS  fluorescence  were
noted from 0 to 10% TFE (Figure 4B). A prominent ANS
increase  was  noted  at  20%  TFE,  indicating  that  a
conformational change of TGFBIp occurred. At 40% TFE, the
ANS fluorescence was significantly reduced.
The far-UV CD spectroscopy (Figure 4C) showed that at
sub-denaturation TFE concentrations (0 to 10%), TGFBIp
appeared to be in a predominantly α-helix conformation. At
20% TFE, a global conformational change of TGFBIp took
place as the α-helix was reduced, with an instant increase of
the ellipticity at 218 nm to β-sheet-dominant species. At 40%
TFE where the co-solvent forms dynamic clusters, TGFBIp
was converted to a non-native α-helix conformer, judging
from the prominent 208/222 nm troughs (Figure 4C).
The solvent effects on the fibril formation were studied
by incubating TGFBIp with TFE at 37 oC for 24 h and then
measured  for  its  ThT  fluorescence.  The  conformation  of
TGFBIp at 0 or 5% TFE remained unchanged after extensive
incubation (48 h, data not shown) and did not produce fibrils
in vitro, whereas significant fibril formation was noted in 10
to 20% TFE, with a slight reduction at 40% TFE after 24 h
incubation  (Figure  4D).  Increasing  the  TFE  concentration
seemed to affect both the yields and the kinetics of fibril
formation (Figure 4D, inset). The fibril formation for TGFBIp
at 20% TFE had a fast onset and produced the highest signal
at 4 h with a slight decrease subsequently. The 40% TFE
produced a quick formation of fibril initially, which was also
supported by the results of oligomeric protofibrillar formation
(cf., Figure 4E, inset), but the ThT signal remained unchanged
subsequently.  TGFBIp  at  10%  TFE  showed  a  slow  fibril
formation, but reached a level higher than that at 40% TFE.
While  10%  TFE  did  not  unfold  TGFBIp  initially,  it
eventually induced conformational changes after extended
incubation, as indicated by the CD spec (Figure 4E). Using a
polyclonal rabbit antibody that specifically recognizes the
universal oligomeric conformers of fibrillar precursors [37],
we further demonstrated that TGFBIp formed oligomers in
the presence of 10% TFE after 2 h, which could be seen in the
dot blot assays used to monitor the oligomeric protofibrillar
formation (Figure 4E, inset). On the other hand, no formation
of oligomer could be detected at 0 or 5% TFE. Prominent
oligomer formations were detected at higher concentrations
(20 and 40%) starting 0.5 hour after incubation with TFE. The
blots were also probed with the α-TGFBIp antibody to ensure
equal loading of proteins in individual wells (data not shown).
DISCUSSION
Extensive and variable post-translational degradation patterns
have been observed for TGFBIp either extracted from tissues,
Figure 2. Intrinsic tryptophan fluorescence was used to investigate the quenching and denaturation of transforming growth factor beta-induced
protein (TGFBIp) A: Fluorescence traces of TGFBIp (0.1 mg/ml) in guanidine hydrochloride (GndHCl), ranging from 0 to 6 M, were shown.
Samples were excited at 295 nm and scanned for the tryptophan emission. Inset: Fluorescence quenching experiments by acrylamide and KI.
B: The emission maximum (Emax) and the intensity-averaged emission maximum (IAEM) were obtained by plotting the intrinsic tryptophan
fluorescence traces versus GndHCl concentrations. Inset: Denaturation experiments by urea at various concentrations. Plot of the shift of
emission maximum versus urea concentration clearly shows that urea fails to unfold TGFBIp, even up to 8 M. C: Thioflavin T (ThT)
fluorescence intensity at 485 nm was used to determine the fibril formation of TGFBIp at various GndHCl concentrations (n=3, bar=S.D.).
Molecular Vision 2009; 15:2617-2626 <http://www.molvis.org/molvis/v15/a279> © 2009 Molecular Vision
2621secreted  by  cultured  cells  or  produced  from  ectopic
mammalian  expression  systems  [19,21,28,38,39],  with  or
without  the  RGD  motif.  A  comparison  study  of  TGFBIp
fragments  extracted  from  normal  and  diseased  corneas
(R124C,  R124H,  and  R124L)  by  2-D  gel  electrophoresis
further  demonstrated  distinct  degenerative  degradations  in
both the N- and C-termini, suggesting differential proteolysis
of  mutant  proteins  [28].  The  current  construct  (“[His]6-
TGFBIp-[Strep II]”) used in our study has generated a highly
purified single TGFBIp protein, compared to the multiple
protein products expressed from the (His)6-TGFBIp construct
or  extracted  from  tissues.  The  homogeneity  and  ease  of
purification  of  this  slightly  truncated,  matured  TGFBIp
circumvent the difficulties in obtaining TGFBIp samples with
high purity and bioactivity (such as the cell adhesion assay)
for  biochemical  and  biophysical  experiments.  As
Figure 3. Acidic pH promotes the fibril
formation  and  fragmentation  of
transforming  growth  factor  beta-
induced  protein  (TGFBIp).  A:
Thioflavin  T  (ThT)  fluorescence
intensity  at  485  nm  was  used  to
determine  the  fibril  formation  of
TGFBIp at various pH conditions (n=5,
bar=S.D.).  Inset:  the  intrinsic
tryptophan  fluorescence  traces  of
TGFBIp  at  pH  3,  7,  and  13.  Inset:
Formations of the fibrillar oligomeric
precursor  of  TGFBIp  at  various  TFE
concentrations were detected by dot blot
experiments.  B:  Chemical
fragmentations  of  TGFBIp  under
neutral  (pH  7)  and  acidic  (pH  3)
conditions  either  at  37  oC  or  60  oC,
analyzed on a 15% SDS-PAGE gel.
Molecular Vision 2009; 15:2617-2626 <http://www.molvis.org/molvis/v15/a279> © 2009 Molecular Vision
2622demonstrated  in  Figure  1C,D,  the  purified  recombinant
TGFBIp can also form amyloid fibrils similar to what other
researchers have previously reported [20].
The  recombinant  TGFBIp  displays  a  two-state
denaturation profile by GndHCl, but not by urea. As urea is a
nonionic  chaotropic  agent  that  denatures  proteins  by
disrupting  the  hydrophobic  interaction,  it  is  likely  that
additional  factors  such  as  electrostatic  interaction  play
significant roles in the folding of TGFBIp. GndHCl, on the
other hand, is an ionic chaotropic species that disrupts both
hydrophobic and electrostatic interactions, which can fully
denature TGFBIp, judging from the emission-maximum shift
of the intrinsic fluorescence. TGFBIp contains a cystine-rich
domain in the NH2-terminus, which potentially can contribute
to the folding of TGFBIp via the intramolecular covalent
disulfide bond; however, incubating TGFBIp in the presence
of urea and reducing agent (dithiothreitol) did not lead to
further denaturation (data not shown), which does not support
the role of disulfide bond in the folding of TGFBIp. The
insights gained from our GndHCl denaturation study will be
useful for a future comparison study of dystrophy-causing
mutants and WT TGFBIp.
Protein conformational changes and unfolding induced
by mutations, oxidation, and other factors have been proposed
to  be  the  pathogenesis  mechanism  for  amyloid  fibril
aggregations  [29,40].  One  hypothesis  for  the  abnormal
aggregation of amyloidogenic proteins is that conformational
change  and/or  protein  unfolding  exposes  the  endogenous
amyloidogenic regions and facilitates their aggregations into
prefibrillar  oligomer  precursors,  fibrils,  and  eventually
Figure  4.  The  trifluoroethanol  (TFE)
effects on the protein conformations of
transforming  growth  factor  beta-
induced protein (TGFBIp) were studied
by  A:  the  intrinsic  tryptophan
fluorescence spectra, B: the 1 anilino-
batgakebe-8-sulfonic  acid  (ANS)
fluorescence  spectra,  and  C:  the  far-
ultraviolet  circular  dichroism  (far-UV
CD) spectra of recombinant TGFBIp at
various  TFE  concentrations.  D:
Thioflavin  T  (ThT)  fluorescence
intensity was used to determine the fibril
formation of TGFBIp at various TFE
concentrations  (n=3,  bar=S.D.).  Inset:
the  fibril  formation  of  TGFBIp  at
various TFE concentrations over a 24 h
period.  E:  Far-UV  CD  spectra  were
obtained by incubating TGFBIp in 10%
TFE for 0 and 2 h. Inset: The dot blot
experiment of TGFBIp probed by the
anti-oligomer antibody.
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2623amyloid  deposits  [41].  It  has  been  shown  previously  that
denaturation or partial unfolding by GndHCl can promote
amyloid fibril formation in various proteins. For example,
GroES (an hsp10 homolog from E. coli) readily forms fibrils
when  partially  denatured  by  GndHCl  [42].  However,
incubating TGFBIp at partially (1 and 2 M) or fully denaturing
(4 M) concentrations did not lead to fibril formation (Figure
2C).  Similarly,  human  and  rat  hsip10  with  sequence
homology to GroES failed to form fibrils under GndHCl-
perturbed states in a recent study [43]. It is likely that while
GndHCl  denatures  these  proteins  and  exposes  their
endogenous amyloidogenic regions, it may also disrupt the
intermolecular  interactions  essential  for  cross-β
oligomerization.
Acidic pH conditions promote fibril formation of Aβ
peptides,  prions,  stefin  B  [44-46],  and  some  non-disease
amyloidogenic proteins, as well as TGFBIp (Figure 3A). In
addition to the destabilizing effect on protein conformation,
low pH conditions can also accelerate the chemical cleavage
of peptide bonds of aspartate and glutamate residues [47],
which can lead to peptide fragmentation. Such an effect on
peptide  fragmentation  can  be  further  enhanced  by  high
temperatures [48,49]. We observed similar fragmentations
and temperature effects with recombinant TGFBIp incubated
under low pH conditions (Figure 3B). While extreme pH is
rarely  encountered  under  normal  physiological  conditions
(except in the lysozyme), fragmentation of proteins is a key
factor  in  initiating  fibril  formation  in  vivo.  Peptide
fragmentation  has  been  shown  to  trigger  amyloid  fibril
aggregations of lactoferrin, amyloid-β protein, gelsolin, and
other proteins [41,50,51]. Deposits of differentially degraded
TGFBIp fragments were noted in the diseased corneas from
dystrophic  patients,  and  may  likely  contribute  to  the
pathogenesis  of  TGFBIp-related  corneal  dystrophies  [28].
Further study on TGFBIp fragments generated by limited
proteolysis or expressed from recombinant sources will help
to  shed  light  on  the  molecular  mechanism  of  TGFBIp
amyloidosis.
TFE  has  been  used  widely  to  investigate  the  solvent
effects on amyloidogenic peptides and proteins. With a low
dielectric constant, and being mildly more acidic than water,
TFE promotes the unfolding and increases the intramolecular
hydrogen bonds in proteins [52]. At low concentrations, TFE
destabilizes  the  specific  tertiary  interactions  of  native
proteins;  at  higher  concentrations,  it  has  been  known  to
stabilize secondary structures (the α-helix) and induce non-
native folded states of proteins [53,54]. TFE can also form
micelle-like  dynamic  clusters  at  higher  concentrations
(>30%) and modulate the molecular properties of proteins. At
the denaturing concentrations, TFE often promotes significant
β-sheet formation, and subsequently leads to fibril formation
[55]. These effects of TFE on the protein conformation of
TGFBIp were also observed. It is clear that TGFBIp formed
the non-native α-helical conformers at a high TFE percentage
(40%) from CD and intrinsic fluorescence results (Figure
4A,C). At 20% TFE, TGFBIp immediately transformed from
an α-helix-enriched native state to a partially denatured state
containing  predominantly  β-sheets  (Figure  4C).  The
transformation not only promoted the aggregating of TGFBIp
into the cytotoxic oligomer (a fibrillar precursor, Figure 4E),
but  also  eventually  led  to  prominent  fibril  formation,
according  to  the  ThT  fluorescence  assays  (Figure  4D).
Although initially TGFBIp remained in its native state at a
sub-denaturation concentration (10%), extended incubation
(after  2  h)  gradually  unfolded  TGFBIp  and  produced
oligomers and amyloid fibrils (Figure 4E).
In  summary,  our  study  has  provided  spectroscopic
characterizations of recombinant TGFBIp in the presence of
denaturants and a co-solvent. Protein unfolding may not be
the only determinant for the fibril formation of TGFBIp. Other
factors, such as solvents, fragmentation, and pH conditions,
also play critical roles. Comparison studies of the molecular
properties  of  WT  and  dystrophic-related  mutant  proteins
(such as R124C for lattice type I) are currently underway in
order  to  shed  light  on  the  pathogenesis  mechanism  of
TGFBIp-related corneal dystrophies.
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